Truist analyst Tobey Sommer raised the firm’s price target on Exponent to $120 from $100 and keeps a Buy rating on the shares. The analyst cites the company’s strong Q2 results, upside Q3 guidance, and rising utilization to 75% from 69%.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXPO: